[Adrenergic components of direct coronary and cardiac action of nitroglycerin].
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D003331:Coronary Vessels / Q000187:drug effects* / Q000294:innervation; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000294:innervation; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D005996:Nitroglycerin / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D013268:Stimulation, Chemical; D013552:Swine; D013564:Sympathetic Nervous System / Q000187:drug effects*
D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D005996:Nitroglycerin
Uber adrenerge Anteile der direkten Koronar- und Herzwirkung des Nitroglycerins